Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 19;59(4):e02403-20.
doi: 10.1128/JCM.02403-20. Print 2021 Mar 19.

A Fast and Accessible Method for the Isolation of RNA, DNA, and Protein To Facilitate the Detection of SARS-CoV-2

Jose Carlos Ponce-Rojas #  1 , Michael S Costello #  1 , Duncan A Proctor  1 , Kenneth S Kosik  1   2 , Maxwell Z Wilson  1   2   3 , Carolina Arias #  4   2 , Diego Acosta-Alvear #  4   2
Affiliations

A Fast and Accessible Method for the Isolation of RNA, DNA, and Protein To Facilitate the Detection of SARS-CoV-2

Jose Carlos Ponce-Rojas et al. J Clin Microbiol. .

Abstract

Management of the coronavirus disease 2019 (COVID-19) pandemic requires widespread testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A main limitation for widespread SARS-CoV-2 testing is the global shortage of essential supplies, among them RNA extraction kits. The need for commercial RNA extraction kits places a bottleneck on tests that detect SARS-CoV-2 genetic material, including PCR-based reference tests. Here, we propose an alternative method we call PEARL (precipitation-enhanced analyte retrieval) that addresses this limitation. PEARL uses a lysis solution that disrupts cell membranes and viral envelopes while simultaneously providing conditions suitable for alcohol-based precipitation of RNA, DNA, and proteins. PEARL is a fast, low-cost, and simple method that uses common laboratory reagents and offers performance comparable to that of commercial RNA extraction kits. PEARL offers an alternative method to isolate host and pathogen nucleic acids and proteins to streamline the detection of DNA and RNA viruses, including SARS-CoV-2.

Keywords: DNA and protein; SARS-CoV-2; field deployable; rapid isolation of RNA; virus detection.

PubMed Disclaimer

Figures

FIG 1
FIG 1
(A) PEARL workflow. (B) Comparative RT-qPCR analysis of the levels of SARS-CoV-2 nucleocapsid (N1) and RNase P RNA sequences in deidentified SARS-CoV-2-positive and -negative clinical specimen samples after RNA extraction using PEARL or an RNA extraction kit (QIAamp Mini Elute virus spin kit) in nasopharyngeal swab samples. Dotted lines indicate a limit of detection of 36 cycles. We obtained Cq values for N1 below our limit of detection in 9 negative samples out of 67. No Cq values were obtained for N1 in the remaining 58 samples. Data points correspond to the reciprocal of the Cq value (1/Cq), which is directly proportional to input RNA. P values and Spearman’s correlation coefficient (ρ) are shown.
FIG 2
FIG 2
(A) RT-qPCR analysis of the levels of KSHV (LANA and GFP) and host β-actin (ACTB) mRNAs and (B) their corresponding genomic sequences. (C) Western blot analysis of the expression of KSHV (LANA and GFP) and host (HSP70) proteins. Inf., infected; Uninf., uninfected.
FIG 3
FIG 3
(A) RT-qPCR analysis of the levels of ZIKV nonstructural proteins NS1 and NS5 and host β-actin (ACTB) mRNAs. (B) qPCR analysis of the expression host ACTB genomic DNA sequences in ZIKV-infected samples. (C) Western blot analysis of expression of ZIKV (NS2B) and host (HSP70) proteins. *, nonspecific band.
See this image and copyright information in PMC

References

    1. CDC. 2019. Novel coronavirus (2019-nCoV) real-time RT-PCR diagnostic panel. CDC, Atlanta, GA. https://www.fda.gov/media/134922/download. - PMC - PubMed
    1. Vogels CBF, Brito AF, Wyllie AL, Fauver JR, Ott IM, Kalinich CC, Petrone ME, Casanovas-Massana A, Muenker MC, Moore AJ, Klein J, Lu P, Lu-Culligan A, Jiang X, Kim DJ, Kudo E, Mao T, Moriyama M, Oh JE, Park A, Silva J, Song E, Takahashi T, Taura M, Tokuyama M, Venkataraman A, Weizman O-E, Wong P, Yang Y, Cheemarla NR, White EB, Lapidus S, Earnest R, Geng B, Vijayakumar P, Odio C, Fournier J, Bermejo S, Farhadian S, Cruz CSD, Iwasaki A, Ko AI, Landry ML, Foxman EF, Grubaugh ND. 2020. Analytical sensitivity and efficiency comparisons of SARS-CoV-2 RT–qPCR primer–probe sets. Nat Microbiol 5:1299–1305. doi: 10.1038/s41564-020-0761-6. - DOI - PMC - PubMed
    1. Esbin MN, Whitney ON, Chong S, Maurer A, Darzacq X, Tjian R. 2020. Overcoming the bottleneck to widespread testing: a rapid review of nucleic acid testing approaches for COVID-19 detection. RNA 26:771–783. doi: 10.1261/rna.076232.120. - DOI - PMC - PubMed
    1. Chomczynski P, Sacchi N. 2006. The single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction: twenty-something years on. Nat Protoc 1:581–585. doi: 10.1038/nprot.2006.83. - DOI - PubMed
    1. Won J, Lee S, Park M, Kim TY, Park MG, Choi BY, Kim D, Chang H, Kim VN, Lee CJ. 2020. Development of a laboratory-safe and low-cost detection protocol for SARS-CoV-2 of the coronavirus disease 2019 (COVID-19). Exp Neurobiol 29:107–119. doi: 10.5607/en20009. - DOI - PMC - PubMed